Paper Details

  1. Home
  2. Paper Details

Ceftriaxone therapy in adults with severe lower respiratory tract infections.

Author: ForderA A, LintonD M, PlumbH, PotgieterP D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Ceftriaxone, a third-generation cephalosporin, was found to be highly effective in treating severe lower respiratory tract infections. In a study of 33 patients, 29 showed a favorable clinical response, and 19 had a favorable bacteriological response. Serum ceftriaxone levels remained above the minimal inhibitory concentrations of sensitive organisms for the entire dosage interval. No side effects attributable to the drug were reported.
Paper Details　
Original Abstract of the Article :
Ceftriaxone, a third-generation cephalosporin with a wide spectrum of antimicrobial activity and a long half-life of 8 hours permitting administration every 24 hours, was evaluated in 33 patients with severe lower respiratory tract infections. Twenty-nine patients showed a favourable clinical respon...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3961646

データ提供：米国国立医学図書館（NLM）

Ceftriaxone Therapy for Severe Lower Respiratory Tract Infections: A New Oasis in the Desert of Antibiotic Resistance

Antibiotic resistance is a growing concern in the desert of infectious diseases. This study explores the efficacy of ceftriaxone, a third-generation cephalosporin, in treating severe lower respiratory tract infections. The researchers, like explorers seeking a new antibiotic solution, evaluated ceftriaxone's effectiveness in 33 patients. They analyzed clinical response, bacteriological response, and serum ceftriaxone levels, searching for evidence of its effectiveness in treating these infections.

Ceftriaxone: A Powerful Weapon in the Fight Against Infection

The study's findings are like a refreshing oasis in the desert of antibiotic resistance. Ceftriaxone demonstrated high efficacy in treating both community-acquired and nosocomial lower respiratory tract infections. The researchers found that ceftriaxone was well-tolerated, with no significant side effects. This suggests that ceftriaxone could be a valuable tool in treating severe lower respiratory tract infections.

Navigating the Desert of Antibiotic Resistance: A Vital Strategy

The study's findings provide valuable insights into the potential of ceftriaxone in treating severe respiratory infections. However, it's important to note that the emergence of antibiotic resistance remains a significant challenge. It's like navigating a desert where the resources are diminishing, and we need to develop new strategies to combat this threat.

Dr.Camel's Conclusion

Ceftriaxone offers a potential solution in the fight against antibiotic resistance. This study highlights the importance of continued research and development of new antibiotics to overcome this growing threat.

Date :
  1. Date Completed 1986-05-15
  2. Date Revised 2014-09-12
Further Info :

Pubmed ID

3961646

DOI: Digital Object Identifier

3961646

Related Literature

Article Analysis
・Side Effects of cefotaxime injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.